After normalizing to β-actin, 168 of the 220 HCC cases (76.4%) showed a ≥2-fold increase of the DLGAP5 mRNA compared with the corresponding non-cancerous livers (P<0.001, Figure 1B). This evidence concerns the gene ACTB and hepatocellular carcinoma.